Treatment of neurodegenerative disease through intracranial delivery of siRNA
AssigneeMedtronic, Inc.
InventorWilliam F. Kaemmerer
Life of this patent
Estimating the term…
Abstract
The present invention provides devices, small interfering RNA, and methods for treating a neurodegenerative disorder comprising the steps of surgically implanting a catheter so that a discharge portion of the catheter lies adjacent to a predetermined infusion site in a brain, and discharging through the discharge portion of the catheter a predetermined dosage of at least one substance capable of inhibiting production of at least one neurodegenerative protein. The present invention also provides valuable small interfering RNA vectors, and methods for treating neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Spinocerebellar Ataxia Type 1, Type 2, Type 3, and/or dentatorubral-pallidoluysian atrophy.
Claims8
A medical system for delivering a small interfering RNA into a pre-determined location in a brain of a patient comprising:
- (a) an intracranial access device;
- (b) a deliverable amount of a small interfering RNA or a vector encoding said small interfering RNA, said small interfering RNA comprising SEQ ID Nos:
- 1 and 2;
- and
- (c) a delivery means for delivering said small interfering RNA or vector encoding said small interfering RNA to said location of the brain of said patient from said intracranial access device through a stereotactically implanted catheter.
Dependencies are inferred from the claim text.